Reposi??o de corticoester?ides em crian?as com choque s?ptico

• Ano de defesa: 2012
• Autor(a) principal: Amoretti, Carolina Friedrich
• Orientador(a): Garcia, Pedro Celiny Ramos
• Tipo de documento: Tese
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Pontif?cia Universidade Cat?lica do Rio Grande do Sul
• Programa de Pós-Graduação: Programa de P?s-Gradua??o em Medicina/Pediatria e Sa?de da Crian?a
• Departamento: Faculdade de Medicina
• País: BR
• Palavras-chave em Português: MEDICINA; PEDIATRIA; HIDROCORTISONA; CORTICOSTER?IDES; HORM?NIO ADRENOCORTICOTR?PICO; CHOQUE S?PTICO; CRIAN?AS; LACTENTE; UNIDADES DE TERAPIA INTENSIVA PEDI?TRICA
• Área do conhecimento CNPq: CNPQ::CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA::PEDIATRIA
• Link de acesso: http://tede2.pucrs.br/tede2/handle/tede/1407

Objectives: To evaluate hydrocortisone treatment and response to ACTH adrenal stimulation test, with or without respect to basal cortisol, in children with volume refractory septic shock.Method: Randomized placebo controlled clinical trial, including children admitted to the Pediatric Intensive Care Unit at S?o Lucas Hospital (HSL-PUCRS, Brazil) with a diagnosis of volume refractory septic shock, between Jun/2008 and Sep/2012. Basal cortisol level was determined and, then, ACTH test (1mcg/1,73m2) was performed. Then, patients were randomized to hydrocortisone or placebo treatment groups. Study protocol was approved by the HSL?s ethics committee.Results: Fifty six patients were analyzed. Median age was 5 months old, and mortality was 17.8%. Mortality rate was higher in patients that failed to respond to ACTH test, regardless of treatment (36% versus 6%; p=0.01). There was no difference between treatment groups regarding time and dose of vasoactive drugs, PICU length of stay and mortality, even when those who fail to respond to ACTH test were analyzed separately.Conclusion: Mortality was higher among patients who failed to respond to ACTH stimulation test, regardless of group of treatment. In our study, steroid replacement in children with volume refractory septic shock failed to improve mortality or any other studied outcome. More studies are needed to confirm these results